HIV can develop resistance to lenacapavir, but at a cost to the virus
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game…
APA Publishing Releases New Titles on Gaming Disorders, HIV Psychiatry, and the Lived Experience of
Washington, D.C. — American Psychiatric Association Publishing has released a new set of titles exploring key areas in…
Long-acting HIV treatment could improve outcomes for breastfeeding women
Sujata Tewari, BA, previously of the Medical Practice Evaluation Center (MPEC) at Massachusetts General Hospital, and Andrea L. Ciaranello, MD, MPH,…
HIV protein Tat found to increase vulnerability to tuberculosis
According to the World Health Organization, tuberculosis accounts for one in three deaths among people living with HIV.…
Researchers uncover how HIV-1 uses RNA:DNA hybrids to integrate into the genome
Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously unknown…